美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR S&P Biotech ETF

154.03

-3.5700-2.27%

盤後：154.100.0700+0.05%19:59 EDT

成交量：1,130.06萬

成交額：17.39億

市值：102.28億

市盈率：8.45

高：157.53

開：157.08

低：152.63

收：157.60

52周最高：169.89

52周最低：93.26

股本：6,640.00萬

流通股本：6,640.00萬

量比：1.47

換手率：17.02%

股息：0.57

股息率：0.37%

每股收益(TTM):18.23

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

醫療健康板塊市場動態綜述

醫療保健板塊動態匯總：市場快訊

美國人口普查局：2025年，92.1%的美國人在部分時段或全年享有醫療保險。

四川雙馬：CDMO業務成功切入歐美主流市場，已與美、歐多家知名生物科技公司建立合作

生物科技公司Electra Therapeutics(ETRA.US)IPO定價14-16美元/股擬籌資3.25億美元

信宸資本聯合領投AI原生Biotech企業宇道生物

鼓勵靈活就業人員參加職工醫保，我國靈活就業人員規模已超過2億人

微博财经-财道工作室

鼓勵靈活就業人員參加職工醫保我國靈活就業人員規模已超過2億人

突破性癌症疫苗引爆生物科技板塊反彈，漲勢能否持續？

公司互動丨這些公司披露在PCB、生物醫藥等方面最新情況

恒指漲，恒科跌，汽車、生物醫藥爆發；光通信、半導體、大模型下挫，智譜跌超9%，兆易創新跌超7% | 港股收盤

每日经济新闻

醫療保健行業動態：市場快評

健康160(02656)開展醫療健康與AI算力融合新業務

商業化放量疊加管線兑現科創板生物醫藥企業進入收穫期

经济参考网

推動AI與醫療健康融合發展三項合作亮相服貿會

经济参考网

邕寧區企業參與項目榮獲廣西科學技術進步獎一等獎

政策解答！事關泰興職工醫保退休待遇

醫療保健板塊市場綜述：諾華、樂敦、手套製造業與IHH等熱點解析

醫療保健板塊動態：市場快訊綜述

內蒙古：圍繞生物食品、生物醫藥、生物化工等重點領域加快實施生物製造產業重點項目

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/XBI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":154.03,"timestamp":1789502400000,"preClose":157.6,"halted":0,"volume":11300561,"hourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"delay":0,"changeRate":-0.02265228426395935,"floatShares":66400000,"shares":66400000,"eps":18.23,"marketStatus":"未開盤","change":-3.57,"latestTime":"09-15 16:00:00 EDT","open":157.08,"high":157.53,"low":152.63,"amount":1738536841.14598,"amplitude":0.031091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":157.6,"sharesOutstanding":63325000,"nav":157.586874,"aum":10743485169.21,"dividendRate":0.003684,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":157.17,"preClose":157.6,"latestTime":"09:29 EDT","volume":2906,"amount":456673.94784,"timestamp":1789478999999,"change":-0.43,"changeRate":-0.002728,"amplitude":0.005162},"postHourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"volumeRatio":1.474873,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1792123200000,"strike":"150.0","timestamp":1789502340274,"price":3.85,"volume":15000,"amount":5775000,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"158.0","timestamp":1789502340274,"price":4.52,"volume":15000,"amount":6780000,"type":"-"}]},"impliedVol":0.319,"impliedVolPercentile":0.6175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.474873,"shares":66400000,"dividePrice":0.5674,"high":157.53,"amplitude":0.031091,"preClose":157.6,"low":152.63,"week52Low":93.26,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.03,"eps":18.23,"divideRate":0.003684,"volume":11300561,"delay":0,"ttmEps":18.23,"open":157.08,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":161.93,"twentyDayClose":159.53,"sixtyDayClose":140.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142651526","title":"醫療健康板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1142651526","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142651526?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 04:52","pubTimestamp":1789505567,"startTime":"0","endTime":"0","summary":"医疗健康领域最新市场快讯，涵盖多家药企与医疗器械公司的股价波动与分析师观点。市场表现方面，阿斯利康股价上涨2.25%，报163.78美元。该股目前下跌1.9%，报113.20瑞郎。杰富瑞对Immutep转持看多立场，分析师David Stanton认为这家生物技术公司的主要候选药物有了更清晰的发展路径。Stanton将评级从持有上调至买入，对该澳大利亚公司关于肺癌研究提前终止似乎与临床因素或试验执行无关的更新感到鼓舞。杰富瑞将目标价翻倍至8澳分。该股持平于4.7澳分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","LABU","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146582906","title":"醫療保健板塊動態匯總：市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1146582906","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146582906?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 00:22","pubTimestamp":1789489368,"startTime":"0","endTime":"0","summary":"贝伦贝格的分析师在最新研报中指出，阿斯利康拥有强劲且多元化的产品组合，其研发管线蕴藏着巨大的潜力。他们认为，这家制药巨头当前管线项目有望实现13%的研发投资回报率。尽管2026年一些备受期待的研究结果遭遇挫折，但这些失利已被其他积极成果所抵消，这恰恰凸显了多元化投资组合的重要性。截至发稿，阿斯利康股价上涨2.25%，报163.78美元。该股持平于4.7澳分。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4588","XBI","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628604","title":"美國人口普查局：2025年，92.1%的美國人在部分時段或全年享有醫療保險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628604","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628604?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 22:09","pubTimestamp":1789481360,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["XBI","LABU","XLV","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667236686","title":"四川雙馬：CDMO業務成功切入歐美主流市場，已與美、歐多家知名生物科技公司建立合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2667236686","media":"财闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667236686?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 21:31","pubTimestamp":1789479060,"startTime":"0","endTime":"0","summary":"9月15日，四川双马(000935.SZ)发布投资者关系活动记录表。其中指出，CDMO业务成功切入欧美主流市场，已与美国、欧洲多家知名生物科技公司建立合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-15/doc-inirxpis3668545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","BK0004","BK4139","BK4588","BK0021","CDMO","000935","GDOC","MEDX","BK4585","BK0028","159837","BK0235","IEIH","HBImain","SYNB","AGNG","LNGR","XBI","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667612838","title":"生物科技公司Electra Therapeutics(ETRA.US)IPO定價14-16美元/股 擬籌資3.25億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667612838","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667612838?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 15:18","pubTimestamp":1789456715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于开发靶向SIRP抗体、用于免疫疾病和癌症治疗的II/III期的生物科技公司Electra Therapeutics周一公布了首次公开募股的发行条款。Electra Therapeutics正在开发一类精准药物，靶向特定免疫细胞群体上表达的信号调节蛋白。Electra Therapeutics欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。汇编数据显示，今年美国生物科技与制药公司的IPO累计募资额已达68亿美元，平均加权回报率接近70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","UUP","UDN","BK4588","LENZ","BK4585","HBImain","ETRA","SYNB","IPOS","GDOC","IBBJ","BK4007","AGNG","BK4539","BK4139","LNGR","MEDX","159837","IEIH","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667692579","title":"信宸資本聯合領投AI原生Biotech企業宇道生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2667692579","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667692579?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 08:52","pubTimestamp":1789433539,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["QTOC","VTHR","AIPO","BK4585","XBI","ARTY","CHAT","BK4588","AGIX","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691484","title":"鼓勵靈活就業人員參加職工醫保，我國靈活就業人員規模已超過2億人","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691484","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691484?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 07:42","pubTimestamp":1789429320,"startTime":"0","endTime":"0","summary":"来源：@21世纪经济报道微博#灵活就业人员买医保更便利了#“鼓励无雇工的个体工商户、未在用人单位参加职工基本医疗保险的非全日制从业人员以及其他灵活就业人员参加职工基本医疗保险。具体办法由国务院医疗保障行政部门会同国务院有关部门制定。”而根据测算，我国灵活就业人员规模已超过2亿人。于保荣说，医疗保障法“鼓励”灵活就业人员参加职工医保，意味着国家倡导灵活就业人员优先选择参加职工医保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2026-09-15/doc-inirwfqa8816026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","XBI","LABU","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667919386","title":"鼓勵靈活就業人員參加職工醫保我國靈活就業人員規模已超過2億人","url":"https://stock-news.laohu8.com/highlight/detail?id=2667919386","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667919386?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 07:31","pubTimestamp":1789428660,"startTime":"0","endTime":"0","summary":"“鼓励无雇工的个体工商户、未在用人单位参加职工基本医疗保险的非全日制从业人员以及其他灵活就业人员参加职工基本医疗保险。具体办法由国务院医疗保障行政部门会同国务院有关部门制定。”而根据测算，我国灵活就业人员规模已超过2亿人。于保荣说，医疗保障法“鼓励”灵活就业人员参加职工医保，意味着国家倡导灵活就业人员优先选择参加职工医保。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-15/doc-inirwfqk3975210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","BK4588","XBI","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198292682","title":"突破性癌症疫苗引爆生物科技板塊反彈，漲勢能否持續？","url":"https://stock-news.laohu8.com/highlight/detail?id=1198292682","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198292682?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 22:44","pubTimestamp":1789397081,"startTime":"0","endTime":"0","summary":"在最新一期《华尔街日报》的《周末展望》节目中，专栏作家戴维·瓦伊纳与联合主持人特利斯·德莫斯及米里亚姆·戈特弗里德齐聚一堂，深入剖析投资者应如何应对今年生物科技与制药领域的火热行情。他们不仅探讨了指数化投资与个股精选孰优孰劣的经典命题，更试图拨开市场情绪的重重迷雾，为投资者拨云见日。值得注意的是，本期节目的视频版本也已同步上线，感兴趣的观众既可于上方直接观看，亦可前往WSJ播客的YouTube频道一探究竟。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664210","title":"公司互動丨這些公司披露在PCB、生物醫藥等方面最新情況","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664210","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664210?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 22:27","pubTimestamp":1789396031,"startTime":"0","endTime":"0","summary":"公司互动丨这些公司披露在PCB、生物医药等方面最新情况","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873742041.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873742041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","PCB","XBI","BK4581","161726","399441","BK4585","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651035","title":"恒指漲，恒科跌，汽車、生物醫藥爆發；光通信、半導體、大模型下挫，智譜跌超9%，兆易創新跌超7% | 港股收盤","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651035","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667651035?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:01","pubTimestamp":1789376513,"startTime":"0","endTime":"0","summary":"9月14日，香港恒生指数收涨0.45%，恒生科技指数跌0.06%。汽车股普涨，广汽集团涨超8%，零跑汽车涨超4%，奇瑞汽车涨超3%，吉利汽车涨近3%；生物医药板块上涨，乐普生物涨超6%，药明康德涨近5%，药明生物涨超4%。大模型概念股下挫，智谱跌超9%，MINIMAX-W跌超6%；光通信、半导体板块下挫，中际旭创跌超8%，剑桥科技跌超8%，兆易创新跌超7%，华虹宏力跌超4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873486194.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873486194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["USD","SIXG","WISE","XSD","161726","TEKX","03032","SOXL","603986","159582","GPTZ","EPAI","07226","03986","SOXY","NBDS","TECY","FOTO","MHImain","02833","09088","SSG","MCHmain","HSI","MQQQ","83115","02513","SOXS","HHImain","399441","FTXL","CWC","PSI","SMH","SOXQ","SOXX","LYTE","LRNZ","KCAI","SMHX","CHPS","513600","XBI","VGT","FWD","CHPY","VXUS","EIS","LUMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178480284","title":"醫療保健行業動態：市場快評","url":"https://stock-news.laohu8.com/highlight/detail?id=1178480284","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178480284?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:27","pubTimestamp":1789374430,"startTime":"0","endTime":"0","summary":"基于此，星展将该股年度利息收入预期在2026至2028年间大幅上调76%，同期盈利预估亦调升6%至21%。星展重申对信达生物的买入评级，并维持144.00港元的目标价。该股现报96.75港元，涨幅3.4%。0155 GMT——丰隆投资银行分析师Andrew Lim在报告中表示，马来西亚医疗保健行业在下半年有望延续增长动能，患者数量及人均收入将持续改善。丰隆投银维持对马来西亚医疗保健行业的增持评级，并将IHH医疗保健集团列为板块首选股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ24219693.SGD","SG9999004220.SGD","LU1282649810.SGD","IE0003895053.USD","SG9999000475.SGD","LU0488056044.USD","LU0672654166.SGD","LU0588545490.SGD","LU0577902371.SGD","LU0577902454.USD","SG9999002406.SGD","LU0823397285.USD","SG9999009443.AUD","LU0251144936.SGD","SG9999001135.SGD","LU0197773673.USD","SG9999013460.SGD","LU0326948709.USD","LU0197773160.USD","LU0557290698.USD","SG9999005177.SGD","SG9999003826.SGD","LU1839390173.USD","SG9999002604.SGD","IE00BKZH1Z71.USD","LU0165289439.USD","LU1497733557.USD","LU1504937902.USD","LU0823413587.USD","LU2506951875.HKD","SG9999013353.USD","SG9999014492.USD","LU2506951958.HKD","SG9999016042.SGD","LU0029875118.USD","LU2237957811.SGD","SG9999008742.SGD","LU0882747503.HKD","LU0886674414.USD","LU0831093199.SGD","SG9999001127.SGD","LU0823417737.USD","LU1497733631.SGD","LU0320764755.SGD","LU0950375773.USD","LU1634259391.SGD","LU0898667661.SGD","LU1282649141.HKD","LU0441851309.USD","SG9999001226.SGD","LU0251143029.SGD","BK4588","SG9999001903.USD","LU0577902298.EUR","LU1282649067.USD","LU0061477393.USD","SGXZ51708014.SGD","SG9999002414.USD","LU0630378692.HKD","SGXZ43160589.SGD","XBI","LU0971096721.USD","LU0878005551.USD","BK6523","IE0031814969.USD","LU0096374516.USD","SG9999002620.SGD","LU0675040207.SGD","LU1770036033.HKD","LU2152927971.USD","LU0762540952.USD","LU0210637038.USD","LU0315178854.USD","SGXZ23024854.USD","BK6112","LU0011963245.USD","LU0048573645.USD","LU0205439572.USD","SG9999002562.SGD","SG9999014484.SGD","LU1956131251.USD","LU0737861269.HKD","SGXZ70427877.SGD","LU0043850808.USD","SG9999014302.SGD","LU0648948544.HKD","LU0823397103.USD","LU0823413660.USD","LU0211331839.USD","SGXZ44547263.SGD","LU0878004406.USD","LU1497734951.SGD","SG9999000343.SGD","LU0261947096.USD","XLV","LU0955669360.SGD","LU0384037296.USD","LU0543330483.HKD","LU0955623706.USD","LU0856984785.SGD","LU0630378429.USD","LU0345776255.USD","D05.SI","SGXZ91733576.SGD","SG9999001846.SGD","LU0577902538.SGD","LU0441854154.USD","LU0823039010.USD","LABU","LU0048597586.USD","LU0128522157.USD","LU0192582467.USD","LU0819123356.HKD","SGXZ58947870.SGD","LU0831103253.SGD","LU0235996351.USD","BK4585","LU0084288322.USD","SG9999000459.SGD","SG9999004360.SGD","LU2257852520.SGD","LU1522347837.USD","LU0873338254.USD","LU0577902611.USD","SG9999013486.USD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999002679.SGD","LU0188438112.USD","LU0345775950.USD","BK6516","SG9999003800.SGD","SG9999013478.USD","LU1211504680.USD","LU2506952097.USD","LU0261945553.USD","LU3227948356.SGD","LU0955648018.USD","LU1130305938.SGD","LU0865486749.SGD","LU1363072403.SGD","LU2506952170.USD","LU0532188223.SGD","SG9999007991.SGD","LU0169518387.USD","LU0823038988.USD","LU0588545904.SGD","SG9999006266.SGD","LU0819121731.USD","LU1634259557.SGD","SG9999011175.SGD","SGXZ27511609.SGD","LU2237957902.USD","BK4581","SG9999003925.USD","LU0823417653.USD","LU0588545730.USD","LU2238330802.EUR","IE00BVYPNP33.GBP","SGXZ16066938.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667312635","title":"健康160(02656)開展醫療健康與AI算力融合新業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2667312635","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667312635?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 07:11","pubTimestamp":1789341110,"startTime":"0","endTime":"0","summary":"董事会认为，该解决方案的顺利交付与验收，是本集团在医疗健康与AI算力融合领域新业务路径的重要探索与关键突破节点。本集团注意到，随着AI技术对医疗健康行业应用的不断深入，持续提升，下游客户对“AI应用+算力基础设施”一体化交付的需求正逐步释放。尤其在智能穿戴健康监测、慢病管理等场景中，AI软件平台与算力基础设施的协同部署已成为医疗健康类企业客户实现业务闭环的关键环节。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IXJ","LABU","VHT","BK1197","BK4550","WISE","BK4585","XBI","159760","BK4581","AIO","XLV","WDAI","02656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667568232","title":"商業化放量疊加管線兑現 科創板生物醫藥企業進入收穫期","url":"https://stock-news.laohu8.com/highlight/detail?id=2667568232","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667568232?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 20:10","pubTimestamp":1789301423,"startTime":"0","endTime":"0","summary":"2026年半年度财报季已收官，在创新药企业以业绩扭亏和BD兑现吸引市场目光的同时，以CXO为代表的上游服务企业正走出周期低谷，单抗、双抗、ADC等核心管线也在临床推进与新增适应症落地中持续兑现价值，勾勒出科创板生物医药企业基本盘企稳、新动能蓄力的图景。创新药企业核心产品持续放量，商业化与国际化双轮驱动业绩改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609133872861973.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609133872861973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","161726","XBI","KSTR","399441","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667686879","title":"推動AI與醫療健康融合發展 三項合作亮相服貿會","url":"https://stock-news.laohu8.com/highlight/detail?id=2667686879","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667686879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 11:50","pubTimestamp":1789271434,"startTime":"0","endTime":"0","summary":"日前，2026年中国国际服务贸易交易会（下称“服贸会”）昌平交易分团举办2026国际健康与环境产业发展系列活动暨中欧跨境产业合作交流会。会上，北京清华长庚医院、北京华医智锦健康科技集团（下称“华医智锦集团”）等开展的“两体融合智联中枢”天健平台启动，AI健康联合研发中心揭牌，AI健康与智联中枢首批协同合作战略协议签署等三项AI健康合作集中亮相。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609133872792846.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609133872792846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159760","BK4581","BK4588","VTHR","XBI","BK4550","XLV","ARTY","CHAT","IXJ","LABU","VHT","AIPO","AGIX","BK4585","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667685237","title":"邕寧區企業參與項目榮獲廣西科學技術進步獎一等獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2667685237","media":"邕宁发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667685237?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 11:07","pubTimestamp":1789268820,"startTime":"0","endTime":"0","summary":"近日，在广西科学技术奖励评选中，由广西医科大学第一附属医院曹存巍教授牵头，广西鹤兰墨广泽生物科技有限公司协同参与的“广西（东盟）重大真菌病精准诊疗与防控关键技术集成及产业化”项目，荣获广西科学技术进步奖一等奖。此次殊荣的获得，是广西鹤兰墨广泽生物科技有限公司长期坚持产学研深度融合发展的成果体现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-13/doc-inirrxsc0620132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGNG","HBImain","GDOC","IBBJ","LNGR","MEDX","SYNB","IEIH","BK4585","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667851836","title":"政策解答！事關泰興職工醫保退休待遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2667851836","media":"泰兴发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667851836?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 10:31","pubTimestamp":1789266660,"startTime":"0","endTime":"0","summary":"我市职工医保退休待遇核定政策解答来了一办理医保退休待遇核定需达到哪些条件？举个例子：2026年泰兴一单位男职工，已交200个月，缴费基数4952元，那么他办理退休时需一次性补缴的医疗保险费用为*10%*4952=49520元；如他有2 年的视同缴费年限，那么他办理退休时需一次性补缴的医疗保险费用为*10%*4952=37635.20元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-13/doc-inirrxsc0610142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147535317","title":"醫療保健板塊市場綜述：諾華、樂敦、手套製造業與IHH等熱點解析","url":"https://stock-news.laohu8.com/highlight/detail?id=1147535317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147535317?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:56","pubTimestamp":1789160215,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场快讯速览——本系列报道聚焦于行业动态，为您捕捉关键信息。0110 ET - 野村证券分析报告称，得益于核心品牌在日本及海外市场的强劲销售势头，乐敦制药本财年业绩有望超越其全年指引。花旗预计，这家医疗器械制造商\"中期内可实现可持续的两位数盈利增长，且相比澳新其他医疗股，受消费端波动的影响更小。该股当前下跌1.3%，报43.37新西兰元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","LABU","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183095065","title":"醫療保健板塊動態：市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1183095065","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183095065?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 00:22","pubTimestamp":1789143768,"startTime":"0","endTime":"0","summary":"最新一期的医疗保健行业市场快讯已发布，涵盖多家业内重要企业的动态。本综述仅在道琼斯通讯社于美东时间4:20、12:20及16:50独家刊出。美东时间1930 - 花旗对斐雪派克医疗持看多立场，认为该公司为投资者提供了增长性与交付可靠性兼备的投资标的。花旗预计，这家医疗器械制造商“中期内将实现可持续的两位数盈利增长，且相较澳新地区其他医疗类股票，其对消费端波动的敞口更低”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4581","LABU","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666540291","title":"內蒙古：圍繞生物食品、生物醫藥、生物化工等重點領域 加快實施生物製造產業重點項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2666540291","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666540291?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:19","pubTimestamp":1789118364,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["XBI","BK4581","161726","399441","159151","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}